A recent study by Demircan and Doğan (2025) evaluated 29 eyes of 24 patients with neovascular glaucoma (NVG ), highlighting its major causes— diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome. Patients had a mean age of 67.9 years, with significantly elevated pre-treatment intraocular pressure (IOP) averaging 36.7 mmHg , which was reduced to 18.0 mmHg post-treatment . Anti-VEGF injections (primarily bevacizumab), panretinal photocoagulation (PRP), and surgical procedures were utilized, with surgery required in 9 cases to achieve adequate IOP control.
While anti-VEGF and PRP effectively reduced neovascularization and IOP, no significant improvement in visual acuity was observed, underscoring the aggressive nature of NVG. The study emphasizes that early diagnosis and multimodal treatment are crucial to minimizing irreversible vision loss. To read more;…
